Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.Journal of aerosol medicine and pulmonary drug delivery · 2024
   Review
2. The need for hypoxic exposure in experimental PAH - Comment on Chen et al.: a novel rat model of pulmonary hypertension induced by mono treatment with SU5416.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
   Article
3. Animal models of right heart failure.Cardiovascular diagnosis and therapy · 2020
   Review
4. Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.American journal of respiratory and critical care medicine · 2020
   Article
5. Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.American journal of respiratory and critical care medicine · 2020
   Article
6. The Adult Sprague-Dawley Sugen-Hypoxia Rat Is Still "the One:" A Model of Group 1 Pulmonary Hypertension: Reply to Le Cras and Abman.American journal of respiratory and critical care medicine · 2020
   Article
7. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.PloS one · 2020
   Article

Corrections and comments

• Commented on by
  Reply to Bogaard2019
• Commented on by
  Early Disruption of VEGF Receptor Signaling and the Risk for Adult Emphysema.2020
• Comment on
  Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.2019

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as